CAUSE (Collaborative for Advancement of Urologic · Sexual · Endocrine education) is a multi-funded educational initiative for urologists, endocrinologists, primary care clinicians, and allied health professionals. Under the guidance of the expert Steering Committees, the collaborative develops and distributes cutting-edge CME-certified materials on erectile dysfunction, hypogonadism, and sexual dysfunction. As its name denotes, CAUSE advocates a multisystem and multidisciplinary approach to men’s overall well-being and sexual health.


Visit Our New Sister Site
Monthly Features
     
TU logo icon
 

The Primary Perspective: Bridging Gaps in Male Urologic and Cardiovascular Health
In this CME satellite symposium Webcast of a live program held in conjunction with AAFP, Culley C. Carson III, MD, and Martin M. Miner, MD, examine strategies to improve the concomitant management of ED, BPH/LUTS, hypogonadism, and CVD with PDE5 inhibitor therapy and testosterone therapy, focusing on how the management of these conditions may improve cardiometabolic parameters and overall health.

There is no charge for this activity.
Activity Approved for CME Credit: 1.25 hours - ACCME, CBRN, AANP

Release Date: November 20, 2014
Expiration Date: November 20, 2015

     
TU logo icon
 

Speaker Ready Slide Lecture Guide Download slides from the satellite symposium, The Primary Perspective: Bridging Gaps in Male Urologic and Cardiovascular Health, held in conjunction with the 2014 AAFP Scientific Assembly.

Jointly provided by and

This program is supported by and independent
educational grant provided by Lilly USA, LLC.



     
DII logo icon
 

Doctor Is In-Case Study 8 Joseph, a 45-year-old male who has end-stage nonischemic dilated cardiomyopathy and has a left ventricular assist device in place, has been referred to a urologist because of his complaint of difficulty with sexual function and activities. Patient history, lab results, and office notes are followed by multiple-choice questions to elicit the diagnoses and treatment plans. Gregory A. Broderick, MD, is faculty.

There is no charge for this activity.
Activity Approved for CME Credit: 1.0 hour - ACCME, CBRN, AANP

Release Date: April 30, 2014
Expiration Date: April 30, 2015

     
TU logo icon
 

herDesire: Clinical Position Paper Based on discussions and interactions at the HD Needs Assessment Roundtable. This program addresses concerns clinicians face and identifies and reviews current gaps in diagnosis and treatment of HSDD.
This activity includes audio clips and interactive elements.

There is no charge for this activity.
Activity Approved for CME Credit: 1.0 hour - ACCME, CBRN, AANP

Release Date: April 4, 2014
Expiration Date: April 4, 2015

     
TU logo icon
 

Advanced Differentiated Thyroid Cancer: Multitargeted Tyrosine Kinase Inhibition to Slow Disease Progression and Prolong Progression Free Survival This monograph by Steven I. Sherman, MD, and Lori Wirth, MD explores advanced differentiated thyroid cancer and its treatment options. Topics include targeted therapeutic treatment approaches, how to manage treatment with tyrosine kinase inhibitors, and future therapies on the horizon.

There is no charge for this activity.
Activity Approved for CME Credit: 1.5 hours - ACCME, CBRN, AANP
Release Date: April 28, 2014
Expiration Date: April 28, 2015

     
TU logo icon
  CME KOL Video Debate Four multidisciplinary key opinion leaders debate cutting-edge issues in 6 videos, each highlighting a different aspect of hypogonadism management. Martin M. Miner, MD (primary care), serves as Chairperson, and the faculty are Adrian S. Dobs, MD, MHS (endocrinology); Robert A. Kloner, MD, PhD (cardiology); and Abraham Morgentaler, MD (urology).
     
TU logo icon
  CME Newsletter Adrian S. Dobs, MD, MHS, and John E. Morley, MB, BCh, discuss the relationship between hypogonadism and osteoporosis.
     
TU logo icon
  CME Case Study 2 Earn free CME credit by participating in the second 3-part Case Study, which follows a patient over the course of 9 months of office visits. A patient history, lab results, and office notes are followed by multiple-choice questions to elicit the diagnosis and treatment plan. Participants may receive CME credit upon completion of each installment of the case study.
     
  CIEF Slide Presentation Builder This feature allows members to download their own PowerPoint® presentation modules on erectile dysfunction and comorbidities, including prevalence and etiology, diagnosis and assessment, and therapeutic options. These slides were specifically developed as a resource for healthcare professionals interested in erectile dysfunction who need customized presentations for speaking engagements.
     
  Refractory Idiopathic and Neurogenic Detrusor Overactivity: Case Studies of Localized Treatment Modalities Access materials presented at the CME-certified symposium exploring the differences between idiopathic and neurogenic overactive bladder (OAB) held in conjunction with the AUA 2011 Annual Meeting. Faculty discussed management and treatment options for refractory OAB (idiopathic and neurogenic). This event was not part of the AUA 2011 Annual Meeting.
 
TU logo icon
  ENDO Conference Courier Report The impact of hypogonadism on men's overall health and well-being was one of the state-of-the-art topics at the Endocrine Society's 93rd Annual Meeting and Expo, held in Boston, Massachusetts, June 4 to 7, 2011. Adrian S. Dobs, MD, MHS, and Christina Wang, MD, serve as faculty for this CME activity. Earn CME credit by reviewing the TestosteroneUpdate Conference Courier Report on highlights of ENDO 2011.
 
TU logo icon
  AUA Conference Courier Report Hypogonadism and its impact on men's health was one of the state-of-the-art topics at the annual meeting of the American Urological Association held May 14 to 19, 2011, in Washington, DC. Martin M. Miner, MD, and Ajay Nehra, MD, serve as faculty for this CME activity. Earn CME credit by reviewing the TestosteroneUpdate Conference Courier Report on highlights of the 2011 AUA Annual Meeting.
 
TU logo icon
  Heart of the Matter: Hypogonadism Management With Testosterone Therapy Access materials presented at the multisponsored CME-certified symposium exploring the relationship between testosterone and cardiovascular disease held in conjunction with the AUA 2011 Annual Meeting. Allen D. Seftel, MD (Chairperson); Adrian S. Dobs, MD, MHS; Robert A. Kloner, MD, PhD; and Martin M. Miner, MD, provided multidisciplinary perspectives on current debates regarding screening, diagnosis, and therapeutic options for hypogonadism.
 
  A Patient-Centered Approach to Management of Metabolic Syndrome With Novel GLP-1 Terapies Earn free CME credit by viewing a symposium on the management of type 2 diabetes originally presented April 6, 2011, at the San Diego Convention Center, in California. This educational activity focuses on the latest clinical data on cardiovascular risk factors and long-acting GLP-1 therapies and emphasizes early, aggressive management of comorbid risk factors and metabolic conditions. This event was not part of the official Internal Medicine 2011 Education Program.
 
  Clinical Consult Shehzad S. Basaria, MD, and Jose M. Garcia, MD, PhD, discuss the potential clinical implications of the latest findings on the relationship between diabetes, metabolic syndrome, and hypogonadism.
 
TU Presentation Builder
  TU Slide Presentation Builder This feature allows members to create their own PowerPoint® presentations online by selecting slides from several modules, including epidemiology, diagnosis and assessment, clinical management and monitoring of the prostate, and current and novel therapeutic options. These slides were specifically developed as a resource for health care professionals interested in hypogonadism who need customized presentations for speaking engagements.
 
CIEF outcomes abstract
CIEF Outcomes Abstract The CIEF abstract Impact of an Educational Initiative on Applied Knowledge and Attitudes of Physicians Who Treat Sexual Dysfunction was presented by Ridwan Shabsigh, MD, at the 2008 American Urological Association Annual Meeting.
     
Coming Soon...
     
CIEF outcomes abstract
 

Outcomes Measurement Study: Phase V This prospective study determines the impact of CIEF initiative activities on clinician learning and behavior and assesses the impact of CME activities on improving sexual health outcomes using validated survey instruments.

     
Have you seen...
 
TU logo icon

CME Newsletter Glenn R. Cunningham, MD, and Robert S. Tan, MD, MBA, survey the range of testosterone formulations, focusing on the gels currently available and those in development, and offer clinical tips for optimizing safety, efficacy, and adherence.

 
TU logo icon

CME Newsletter Ronald S. Swerdloff, MD, and Wayne J.G. Hellstrom, MD, respond to public confusion of anabolic-androgenic steroid abuse and testosterone therapy.

 

 

CAUSE is your one-stop portal for

Jointly sponsored by 
 and 
© 2014 CogniMed Inc. All rights reserved.